• Skip to main content

Parkinson’s Treatment Report

www.ParkinsonsTreatmentReport.com

IPX203

A Study to Evaluate the Safety and Efficacy of IPX203 in Parkinson’s Disease Patients With Motor Fluctuations

May 16, 2019

https://clinicaltrials.gov/ct2/show/NCT03670953?recrs=abdef&type=Intr&cond=Parkinson+Disease&phase=0124&lupd_s=05%2F02%2F2019&lupd_d=14&sort=nwst

STUDY TITLE:
A Study to Evaluate the Safety and Efficacy of IPX203 in Parkinson’s Disease Patients With Motor Fluctuations

DESCRIPTION:
Condition:   Parkinson’s Disease (Disorder)
Interventions:   Drug: IR CD-LD;   Drug: IPX203 ER CD-LD;   Other: IPX203 placebo;   Other: IR CD-LD placebo
Sponsor:   IMPAX Laboratories, Inc.
Recruiting

CLINICALTRIALS.GOV IDENTIFIER:
NCT03670953

FIRST POSTED:
Fri, 14 Sep 2018 12:00:00 EDT

LAST UPDATE POSTED:
05/16/19 07:19AM

STUDY LINK / URL:
https://clinicaltrials.gov/ct2/show/NCT03670953?recrs=abdef&type=Intr&cond=Parkinson+Disease&phase=0124&lupd_s=05%2F02%2F2019&lupd_d=14&sort=nwst

Powered by Urgent Research

Copyright © 2025 Urgent Research